Cargando…

Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task

Besides the memory impairment, Alzheimer’s disease (AD) is often complicated by neuropsychiatric symptoms also known as behavioral and psychological symptoms of dementia, which occur in one-third of patients at an early stage of the disease. Although the relationship between depressive disorders and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cassano, Tommaso, Calcagnini, Silvio, Carbone, Antonio, Bukke, Vidyasagar Naik, Orkisz, Stanislaw, Villani, Rosanna, Romano, Adele, Avolio, Carlo, Gaetani, Silvana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777507/ https://www.ncbi.nlm.nih.gov/pubmed/31611786 http://dx.doi.org/10.3389/fphar.2019.01067

Ejemplares similares

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020)

The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020)

The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020)

PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer’s Disease
por: Cassano, Tommaso, et al.
Publicado: (2023)

Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2021)

Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease
por: Bellanti, Francesco, et al.
Publicado: (2017)

Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
por: Cassano, Tommaso, et al.
Publicado: (2017)

Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease
por: Sangineto, Moris, et al.
Publicado: (2023)

Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues
por: Gallelli, Cristina Anna, et al.
Publicado: (2018)

Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Editorial: Alzheimer’s Disease: Original Mechanisms and Translational Impact
por: Mancuso, Cesare, et al.
Publicado: (2020)

Preclinical and clinical issues in Alzheimer's disease drug research and development
por: Mancuso, Cesare, et al.
Publicado: (2014)

From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders
por: Romano, Adele, et al.
Publicado: (2016)

Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals?
por: Romano, Adele, et al.
Publicado: (2015)

A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model
por: Sangineto, Moris, et al.
Publicado: (2021)

Astrocyte Function Is Affected by Aging and Not Alzheimer’s Disease: A Preliminary Investigation in Hippocampi of 3xTg-AD Mice
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2019)

Depressive-Like Behavior Is Paired to Monoaminergic Alteration in a Murine Model of Alzheimer’s Disease
por: Romano, Adele, et al.
Publicado: (2015)

From Obesity Resistance to Obesity Prediction and Prevention?
por: Gaetani, Silvana, et al.
Publicado: (2016)

Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives
por: Villani, Rosanna, et al.
Publicado: (2023)

Aberrant insulin signaling in Alzheimer's disease: current knowledge
por: Bedse, Gaurav, et al.
Publicado: (2015)

Oleoylethanolamide: A Novel Potential Pharmacological Alternative to Cannabinoid Antagonists for the Control of Appetite
por: Romano, Adele, et al.
Publicado: (2014)

Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease
por: Carapelle, Elena, et al.
Publicado: (2020)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Advances in Alzheimer’s disease’s pharmacological treatment
por: Conti Filho, Carlos Elias, et al.
Publicado: (2023)

Modulation of Pain Sensitivity by Chronic Consumption of Highly Palatable Food Followed by Abstinence: Emerging Role of Fatty Acid Amide Hydrolase
por: Cifani, Carlo, et al.
Publicado: (2020)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
por: Cuello, A. Claudio, et al.
Publicado: (2019)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease
por: Shi, Zhikun, et al.
Publicado: (2022)

Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2022)

Pharmacological models in Alzheimer's disease research
por: Gilles, Christian, et al.
Publicado: (2000)

Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2018)

Editorial: Innovation in ocular pharmacology
por: Gozzo, Lucia, et al.
Publicado: (2023)

Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer’s Disease: A Narrative Review
por: Di Giacomo, Silvia, et al.
Publicado: (2022)

Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer’s Disease: A Systematic Review
por: Theleritis, Christos G., et al.
Publicado: (2019)

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
por: Luo, Yunxia, et al.
Publicado: (2020)

Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease
por: Sharma, Abha, et al.
Publicado: (2018)

Network Pharmacology-Based Analysis of Xiao-Xu-Ming Decoction on the Treatment of Alzheimer’s Disease
por: Shen, Yanjia, et al.
Publicado: (2020)

Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease
por: McKee, Chloe G., et al.
Publicado: (2023)

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer’s disease
por: Luo, Yunxia, et al.
Publicado: (2023)

Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the “less is more” perspective
por: Villani, Rosanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_miecnvdlfcgpac1olrlhm6rbbv